Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Arcutis Biotherapeutics Inc shares valued at $86,691 were purchased by Heron Patrick J on May 14 ’25. At $13.76 per share, Heron Patrick J acquired 6,300 shares. The insider’s holdings grew to 14,974 shares worth approximately $0.2 million following the completion of this transaction.
Also, Heron Patrick J purchased 2,374 shares, netting a total of over 32,661 in proceeds. Following the buying of shares at $13.76 each, the insider now holds 8,674 shares.
Before that, Heron Patrick J had added 6,300 shares to its account. In a trade valued at $85,691, the Director bought Arcutis Biotherapeutics Inc shares for $13.60 each. Upon closing the transaction, the insider’s holdings increased to 6,300 shares, worth approximately $85869.0.
As published in their initiating research note from H.C. Wainwright on December 30, 2024, Arcutis Biotherapeutics Inc [ARQT] has been a Buy and the price target has been revised to $19. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in late August. As of January 03, 2024, Mizuho has increased its “Neutral” rating to a “Buy” for ARQT. Earlier on October 26, 2023, Mizuho downgraded its rating. Their new recommendation was “a Neutral” for ARQT stock which previously was a “a Buy”.
Analyzing ARQT Stock Performance
During the last five days, there has been a surge of approximately 0.85%. Over the course of the year, Arcutis Biotherapeutics Inc shares have dropped approximately -2.15%. Shares of the company reached a 52-week high of $17.75 on 03/25/25 and a 52-week low of $11.13 on 02/11/25. A 50-day SMA is recorded $14.77, while a 200-day SMA reached $12.15.
Support And Resistance Levels for Arcutis Biotherapeutics Inc (ARQT)
According to the 24-hour chart, there is a support level at 13.37, which, if violated, would cause prices to drop to 13.10. In the upper region, resistance lies at 13.84. The next price resistance is at 14.04. RSI (Relative Strength Index) is 44.68 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.60, which suggests the price will decrease in the coming days. Percent R is at 62.77%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
